Bethanechol chloride oral solutions: stability and use in infants.

Abstract

OBJECTIVE:

To assess the stability of a bethanechol chloride oral solution prepared from tablets.

METHOD:

The initial concentrations were determined. These solutions were stored at 4 degrees C for 90 days. During this period, the concentrations of the bethanechol chloride solutions were determined by spectrophotometry. The clinical efficacy of the oral solution was tested in five infants with gastroesophageal reflux disease by comparison of gastric pH before and after treatment.

RESULTS:

Significant decomposition of bethanechol chloride occurred in the two formulations. Bethanechol oral solution in sterile water for irrigation was well tolerated by five pediatric patients, and the clinical efficacy was equivalent to that of the tablet formulation.

CONCLUSIONS:

The bethanechol chloride oral solution 1 mg/mL in sterile water for irrigation was stable at least 30 days when stored at 4 degrees C and at an initial pH of 6.5. This formulation appears to be clinically acceptable and provides a convenient dosage form for use in pediatric patients.

• Authors: J L Schlatter, J L Saulnier
• Journal: The Annals of pharmacotherapy (Ann Pharmacother) Vol. 31 Issue 3 Pg. 294-6 (Mar 1997) ISSN: 1060-0280 [Print] United States
• PMID: 9066934 (Publication Type: Clinical Trial, Comparative Study, Journal Article)

Chemical References

• Muscarinic Agonists
• Parasympathomimetics
• Solutions
• Tablets
• Bethanechol
• Water

Topics

• Bethanechol (administration & dosage, chemistry)
• Drug Stability
• Gastric Acid (metabolism)
• Gastroesophageal Reflux (drug therapy, physiopathology)
• Humans
• Infant
• Muscarinic Agonists (administration & dosage, chemistry)
• Parasympathomimetics (administration & dosage, chemistry)
• Solutions
• Tablets
• Water